EP Patent

EP3621628B1 — Method for treating multiple sclerosis using arsenic trioxide

Assigned to Medsenic · Expires 2024-12-25 · 1y expired

What this patent protects

Patent listed against Aubagio.

Drugs covered by this patent

Aubagio (TERIFLUNOMIDE) · Sanofi

Patent Metadata

Patent number: EP3621628B1
Jurisdiction: EP
Classification: —
Expires: 2024-12-25
Drug substance claim: No
Drug product claim: No
Assignee: Medsenic
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.